Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents.
about
Quantitative contrast-enhanced ultrasound imaging: a review of sources of variabilityThe local effects of ovarian diathermy in an ovine model of polycystic ovary syndrome.Pixel-based approach to assess contrast-enhanced ultrasound kinetics parameters for differential diagnosis of rheumatoid arthritis.Recent developments in dynamic contrast-enhanced ultrasound imaging of tumor angiogenesis.Validation of dynamic contrast-enhanced ultrasound in rodent kidneys as an absolute quantitative method for measuring blood perfusionUtility of quantitative contrast-enhanced ultrasound for the prediction of extracapsular extension in papillary thyroid carcinoma.Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study.Three-dimensional Dynamic Contrast-enhanced US Imaging for Early Antiangiogenic Treatment Assessment in a Mouse Colon Cancer Model.A comparison of radial keyhole strategies for high spatial and temporal resolution 4D contrast-enhanced MRI in small animal tumor models.Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinomaIntra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.Dynamic contrast-enhanced ultrasound for quantification of tissue perfusion.Compound speckle model detects anti-angiogenic tumor response in preclinical nonlinear contrast-enhanced ultrasonography.Multiparametric dynamic contrast-enhanced ultrasound imaging of prostate cancer.Tissue perfusion modelling in optical coherence tomographyContrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.Bolus versus continuous infusion of microbubble contrast agent for liver ultrasound by using an automatic power injector in humans: A pilot study.Improvement of the accuracy of liver lesion DCEUS quantification with the use of automatic respiratory gating.Citrulline does not enhance blood flow, microvascular circulation, or myofibrillar protein synthesis in elderly men at rest or following exercise.Quantitative Three-Dimensional Dynamic Contrast-Enhanced Ultrasound Imaging: First-In-Human Pilot Study in Patients with Liver Metastases.Parameters for Contrast-Enhanced Ultrasound (CEUS) of Enlarged Superficial Lymph Nodes for the Evaluation of Therapeutic Response in Lymphoma: A Preliminary Study.Assessment of liver fibrosis by ultrasound elastography and contrast-enhanced ultrasound: a randomized prospective animal study.Contrast-enhanced ultrasound using real-time contrast harmonic imaging in invasive breast cancer: comparison of enhancement dynamics with three different doses of contrast agent.Correlation of contrast-enhanced ultrasound kinetics with prognostic factors in invasive breast cancer.Reproducibility of Contrast-Enhanced Ultrasound in Mice with Controlled Injection.Early prediction of tumor response to bevacizumab treatment in murine colon cancer models using three-dimensional dynamic contrast-enhanced ultrasound imaging.
P2860
Q24605553-083F9153-BB66-4A15-9689-E0B7208F1DF9Q30303058-B55661FE-A4EE-46C6-B67F-3B47FF7A9034Q30374689-4A92E95E-05C7-4255-B831-626018FF0A86Q30419728-56F631FC-EB54-4DE9-8B47-C9D71FA78310Q30467253-D2DA67F6-58FA-4DC4-960D-67CEF9511B2AQ33684552-88871133-80F6-42C8-B9EC-C4D800232E91Q34465123-0D3FE70C-D7BB-4451-B442-30FD7ACA4842Q36232472-1B81D3D9-2189-4D8F-97D0-177731B1EC88Q36581620-633D1215-6B03-468D-B302-202926A1785CQ36715988-CEF50A90-1BF1-4718-86E4-A75E3B03F14FQ37616769-0A132EA0-9CAC-4ED5-8C18-C41E88233B5EQ38329582-BC8B4E7F-668F-4118-A809-FD4A5370FD2EQ38720584-727FA4CA-954E-4F24-BDAA-CAA638B391B5Q38779464-4237C086-8EED-4583-AC88-8A1F3EAAE948Q38971455-329164F8-0722-4259-ABBE-9CB9FE73CA2DQ39556976-DF951F07-0DFD-494D-8905-3AEB5DE7FA69Q40612757-2FA176E5-9DD9-4240-9FB8-C08C6D69D3E9Q40996922-EFD6BC47-D9CE-42B7-90AE-8CC44E260285Q42458896-E999D708-470A-4DBD-9B29-84050543EC63Q46845477-2136792F-DCFE-4E24-A9C1-507458B21858Q47130685-9E62C3FD-6633-4331-BDC6-FDA5B45B5114Q50224570-C88CFD5E-7023-4F56-A654-2CBB72C09E0EQ53082668-47DF774A-B61B-4498-AF01-638A54B257A0Q53103147-9652DB91-48DD-4CF2-97EB-F48167B844AEQ53122944-FDCF04DA-6EE6-49ED-834C-FEFA15288745Q53155777-F7CC6965-27E5-481D-84E0-4C1CADC69CB4
P2860
Indicator dilution models for the quantification of microvascular blood flow with bolus administration of ultrasound contrast agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Indicator dilution models for ...... of ultrasound contrast agents.
@en
Indicator dilution models for ...... of ultrasound contrast agents.
@nl
type
label
Indicator dilution models for ...... of ultrasound contrast agents.
@en
Indicator dilution models for ...... of ultrasound contrast agents.
@nl
prefLabel
Indicator dilution models for ...... of ultrasound contrast agents.
@en
Indicator dilution models for ...... of ultrasound contrast agents.
@nl
P2093
P356
P1476
Indicator dilution models for ...... of ultrasound contrast agents
@en
P2093
Alan McNeilly
Marios Lampaskis
Michalakis Averkiou
P304
P356
10.1109/TUFFC.2010.1550
P577
2010-06-01T00:00:00Z